Gynae BT 2017

Vaginal stenosis and ICRU recto-vaginal point (630 pts)

Cox-regression, 2 year actuarial risk of ≥G2 stenosis - Significant impact of EBRT dose (45Gy versus 50Gy) - Significant impact of BT ICRU recto-vaginal dose

Prevalence vaginal stenosis

100%

90%

80%

70%

60%

G0 G1 G2 G3

50%

40%

30%

20%

10%

0%

3M 6M 9M 12M 18M 24M 30M 36M

Kirchheiner K et al.Manifestation pattern of early-late vaginal morbidity. IJROBP 2014 May 1;89(1):88-95

K Kirchheiner et al, EMBRACE data MUW/AUH, RadiothOncol 2016

24